StockData
Mirum Pharmaceuticals, Inc. logo

Mirum Pharmaceuticals, Inc. (MIRM) bonds

MIRMNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 5/30
$91.95+0.37 (+0.40%)

Close on Nov 17, 2026Market cap $5.97BP/E –Yield –

Debt

Borrowings on the balance sheet, Jun 30, 2026

Mirum Pharmaceuticals reports no long-term debt line

Its balance sheet in XBRL does not include long-term debt, so totals and interest cost cannot be shown.

Notes and loans outstanding

As tagged in Mirum Pharmaceuticals's 10-Q for the period ended Jun 30, 2026

IssueCouponMaturesAmount issuedCarrying value
Senior Notes Due At 20294.00%2029$79.04M$77.66M
Convertible Senior Notes due 2032
Convertible at $139 a share
–2032$690.00M–
Senior Notes Due At 20320.00%2032$690.00M$672.42M
Senior Notes Due At Two Thousand Twenty Nine4.00%–$316.23M$309.80M
Senior Subordinated Convertible Note
Convertible
––$769.00M–

Companies tag their debt differently: some list every note, others group notes by issuance year or by type, so the list may not add up to total debt. Notes that matured before today are hidden. Source: 10-Q.

See a number that looks wrong?